MaaT Pharma

📍 Lyon, France🗓 Founded 2014👥 74 employees💰 Last funded Aug 2025
Biotechnology Research🌐 maatpharma.com
Website LinkedIn
MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021.
4
Total investors
2
Early stage
0
Mid stage
1
Late stage
2014
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
France
2
Luxembourg
1
Investor activity2015–2025 · investors recorded per year
20151201612021120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MaaT Pharma?
MaaT Pharma has 4 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did MaaT Pharma last raise funding?
The most recent investment in MaaT Pharma recorded on gritt.io was in August 2025.
When was MaaT Pharma founded?
MaaT Pharma was founded in 2014.
What industry is MaaT Pharma in?
MaaT Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MaaT Pharma based?
MaaT Pharma is headquartered in Lyon, France.